Cytokine storm in COVID ‐19 and parthenolide: Preclinical evidence-Reference-Cited by-同舟云学术

Cytokine storm in COVID ‐19 and parthenolide: Preclinical evidence

Author:

Bahrami Mohsen¹^ORCID,Kamalinejad Mohammad²,Latifi Seied Amirhossein³,Seif Farhad⁴⁵^ORCID,Dadmehr Majid⁶^ORCID

Affiliation:

1. Academic Center for Education Culture and Research Tehran Iran

2. School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran

3. Traditional and Complementary Medicine Research Center Arak University of Medical Sciences Arak Iran

4. Department of Immunology & Allergy Academic Center for Education, Culture, and Research Tehran Iran

5. Neuroscience Research Center Iran University of Medical Sciences Tehran Iran

6. School of Persian Medicine Iran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Pharmacology

Link

Reference12 articles.

1. Herbal medicines for immunosuppression;Amirghofran Z.;Iranian Journal of Allergy, Asthma, and Immunology,2012

2. COVID‐19: Immunopathology and its implications for therapy. Nature reviews;Cao X.;Immunology,2020

4. A review on the therapeutic potentials of parthenolide: A sesquiterpene lactone;George V.;International Research Journal of Pharmacy,2012

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献